Role of the inflammasome, gasdermin D, and pyroptosis in non-alcoholic fatty liver disease

Pyroptosis is a type of programmed cell death mediated by a multiprotein complex called the inflammasome through the pro-inflammatory activity of gasdermin D. This study aimed to recognize the final biological product that leads to pore formation in the cell membrane, lysis, pro-inflammatory cytokines release, and the establishment of an immune response. An exhaustive search engine investigation of an elevated immune response can induce a sustained inflammation that directly links this mechanism to non-alcoholic fatty liver disease and its progression to non-alcoholic steatohepatitis. Clinical studies and systematic reviews suggest that gasdermin D is a critical molecule between the immune response and the disease manifestation, which could be considered a therapeutic target for highly prevalent diseases characterized by presenting perpetuated inflammatory processes. Both basic and clinical research show evidence on the expression and regulation of the inflammasome-gasdermin D-pyroptosis trinomial for the progression of non-alcoholic fatty liver disease to non-alcoholic steatohepatitis.

Automated summary

Pyroptosis is a type of programmed cell death mediated by the inflammasome through the pro-inflammatory activity of gasdermin D. Research indicates that gasdermin D plays a crucial role in connecting an elevated immune response to a sustained inflammation, linking it to the progression of non-alcoholic fatty liver disease to non-alcoholic steatohepatitis. Both basic and clinical studies show evidence supporting gasdermin D as a potential therapeutic target for diseases characterized by perpetuated inflammatory processes.